BTI forms magnetic-sensor joint venture

Article

Biomagnetic Technologies of San Diego has formed a joint venture with another firm to develop high-temperature superconductive technology. In forming the joint venture, called Magnesensors, BTI will contribute its clean-room facility and superconducting

Biomagnetic Technologies of San Diego has formed a joint venture with another firm to develop high-temperature superconductive technology. In forming the joint venture, called Magnesensors, BTI will contribute its clean-room facility and superconducting device fabrication processes, while its partner, Quantum Magnetics of San Diego, will add its backlog of R&D contracts in the technology.

BTI and Quantum believe the technology to be developed by Magnesensors could be used for both healthcare and non-healthcare applications. For example, it could be used to monitor heart function of a fetus during pregnancy, or for industrial uses like detecting explosives. Magnesensors will be headed by former BTI veteran Mark Dilorio as president and CEO, and will start with equipment and personnel from both companies.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.